This compound is an Fmoc-protected amino acid derivative used as a building block in solid-phase peptide synthesis. It features a 2,2-dimethyloxazolidine ring system, which provides structural rigidity during peptide assembly.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 878797-01-4
Fmoc-Tyr(tBu)-Ser(Psi(Me,Me)pro)-OH
research compound
Fmoc-Leucine-Serine Pseudoproline
pharmaceutical intermediate
(4S)-3-[(2S)-2-[[(9H-Fluoren-9-ylmethoxy)carbonyl]amino]-1-oxopropyl]-2,2-dimethyl-4-oxazolidinecarboxylic acid
research compound
4-Oxazolidinecarboxylic acid, 3-[(2S)-3-(1,1-dimethylethoxy)-2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-1-oxopropyl]-2,2-dimethyl-, (4S)-
pharmaceutical intermediate
4-Chloro-2,5-difluorobenzaldehyde
pharmaceutical intermediate
(R)-tert-Butyl [[piperidin-3-yl]methyl]carbamate
pharmaceutical intermediate
(R)-3-N-Cbz-aminopyrrolidine
pharmaceutical intermediate
1-(Propan-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole
pharmaceutical intermediate
(4S)-3-[(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-phenylpropanoyl]-2,2-dimethyl-1,3-oxazolidine-4-carboxylic acid
PQJUKTSKOYOXMZ-UIOOFZCWSA-N
CC1(N([C@@H](CO1)C(=O)O)C(=O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3C4=CC=CC=C4C5=CC=CC=C35)C